Xenco Medical Expands its Global Footprint with Distribution Hubs Across the United Arab Emirates, Saudi Arabia, Singapore, and Oman

SAN DIEGO–(BUSINESS WIRE)–Pioneering medical technology company Xenco Medical today announced the expansion of its international distribution hubs across the United Arab Emirates, the Kingdom of Saudi Arabia, Singapore, and the Sultanate of Oman, marking a significant milestone in the company’s mission to deliver advanced surgical solutions to healthcare systems around the world. The strategic expansion strengthens Xenco Medical’s presence across key global healthcare markets, bringing its next-generation biomimetic implants, regenerative biomaterials, and composite polymer surgical technologies to leading hospitals and surgeons throughout the Middle East and Southeast Asia.

Through its newly established regional partnerships, Xenco Medical will support a growing number of orthopedic and surgical centers with its comprehensive portfolio of logistics-optimized, single-use implant and instrument systems designed to enhance procedural efficiency, reduce hospital overhead, and improve patient outcomes. The expansion reflects accelerating global demand for Xenco Medical’s innovative technologies that integrate regenerative science, advanced materials, and AI-driven software to redefine the continuum of surgical care.

“A testament to the universal resonance of our breakthrough technologies, we have been immensely excited by the enthusiastic embrace of Xenco Medical across global markets, demonstrating the ability of scientific advancements to traverse continents. We look forward to translating our growing presence in the Middle East and Southeast Asia into transformative patient outcomes,” said Xenco Medical Founder and CEO Jason Haider.

Inspired by the principles of mechanotransduction, Xenco Medical’s proprietary TrabeculeX Continuum platform harmonizes regenerative biomaterials with AI-powered post-surgical rehabilitation, enabling clinicians to monitor pain scores, patient adherence, and motion recovery through remote, AI-driven pose assessment. The introduction of this integrated ecosystem into new international markets underscores Xenco Medical’s commitment to advancing value-based healthcare worldwide.

The Middle East and Southeast Asia represent some of the fastest-growing healthcare markets globally, driven by investments in hospital infrastructure, medical tourism, and digital health transformation. Xenco Medical’s expansion into these regions positions the company to support these evolving healthcare ecosystems with scalable, sustainable, and clinically differentiated solutions that reduce waste, streamline logistics, and elevate the standard of surgical care. With its logistics-optimized, single-use implant systems eliminating the need for sterilization and reprocessing between procedures, Xenco Medical’s technologies significantly reduce surgical turnover times while improving consistency and safety in operating rooms. These advantages are expected to deliver immediate operational and economic value to healthcare facilities across the newly established Xenco Medical distribution hubs.

As Xenco Medical continues to rapidly grow its global footprint, the company remains focused on translating the promise of biomimetic implants, regenerative medicine, and artificial intelligence into meaningful outcomes for patients and providers alike, bringing its vision of a more longitudinally connected, efficient, and patient-centered surgical ecosystem to healthcare systems around the world. In recognition of its commitment to delivering breakthroughs in global healthcare, Xenco Medical was named one of the World’s Most Innovative Companies by Fast Company Magazine for the second time in 2025, the winner of the World Economic Forum’s 2025 Award for Excellence in Governance and Leadership for Global Challenges, and the 2025 Medical Device/Diagnostics Company of the Year at the prestigious Trailblazer Awards in New York City.

Contacts

Melissa Russell

858-202-1505

[e-mail]